This was recently demonstrated in a clinical study using reovirus to treat high-grade glioma and brain metastases, where preconditioning of the tumor immune microenvironment by the virus upregulated tumor PD-L1 protein expression.24 This evidence concerns the gene CD274 and neoplasm.